• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

beta-Lactam MICs correlate poorly with mutant prevention concentrations for clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa.

作者信息

Gugel Juliana, Dos Santos Pereira Andrea, Pignatari Antônio C C, Gales Ana C

出版信息

Antimicrob Agents Chemother. 2006 Jun;50(6):2276-7. doi: 10.1128/AAC.00144-06.

DOI:10.1128/AAC.00144-06
PMID:16723607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1479105/
Abstract
摘要

相似文献

1
beta-Lactam MICs correlate poorly with mutant prevention concentrations for clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa.β-内酰胺类药物的最低抑菌浓度（MIC）与不动杆菌属和铜绿假单胞菌临床分离株的突变预防浓度相关性较差。
Antimicrob Agents Chemother. 2006 Jun;50(6):2276-7. doi: 10.1128/AAC.00144-06.
2
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.铜绿假单胞菌和不动杆菌属中左氧氟沙星、环丙沙星单独及与β-内酰胺类和阿米卡星联合使用时的体外耐药性选择
J Antimicrob Chemother. 2005 Aug;56(2):353-9. doi: 10.1093/jac/dki204. Epub 2005 Jun 20.
3
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.不动杆菌属和铜绿假单胞菌的多药耐药机制。
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S49-56. doi: 10.1086/504477.
4
Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.在耐碳青霉烯类铜绿假单胞菌高流行率背景下，多重耐药不动杆菌属菌株中碳青霉烯类药物的敏感性稳定率。
Int J Antimicrob Agents. 2007 Aug;30(2):187-9. doi: 10.1016/j.ijantimicag.2007.03.001. Epub 2007 Apr 23.
5
[Study on the drug-resistant genes associated with beta-lactams and aminoglycosides in clinically isolated Pseudomonas aeruginosa].[临床分离铜绿假单胞菌中与β-内酰胺类和氨基糖苷类相关的耐药基因研究]
Zhonghua Shao Shang Za Zhi. 2007 Apr;23(2):108-11.
6
Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.铜绿假单胞菌和不动杆菌属中的金属β-内酰胺酶
Expert Opin Investig Drugs. 2008 Feb;17(2):131-43. doi: 10.1517/13543784.17.2.131.
7
The challenge of multidrug resistance: the treatment of gram-negative rod infections.多重耐药性的挑战：革兰氏阴性杆菌感染的治疗
Shock. 2008 Oct;30 Suppl 1:30-3. doi: 10.1097/SHK.0b013e3181819cb8.
8
Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.β-内酰胺诱导革兰氏阴性菌形成丝状结构的浓度依赖性
Clin Microbiol Infect. 2008 Apr;14(4):344-9. doi: 10.1111/j.1469-0691.2007.01940.x. Epub 2008 Feb 5.
9
Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp.评估Etest MBL检测铜绿假单胞菌属和不动杆菌属中携带blaIMP-1和blaVIM-2等位基因的临床分离株的能力
J Clin Microbiol. 2005 Feb;43(2):942-4. doi: 10.1128/JCM.43.2.942-944.2005.
10
Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species.针对几乎完全耐药的铜绿假单胞菌和不动杆菌属感染的新型抗生素组合。
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S95-9. doi: 10.1086/504486.

引用本文的文献

1
Beta-Lactam Antibiotic Concentrations and the Acquisition of Multi-Drug Resistant Bacteria in Critically Ill Patients.β-内酰胺类抗生素浓度与重症患者多重耐药菌的获得
Life (Basel). 2025 May 2;15(5):739. doi: 10.3390/life15050739.
2
Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing .美罗培南在标准接种量和高接种量时的最低抑菌浓度及突变预防浓度的相互关系：与非产碳青霉烯酶菌株、产OXA-48、KPC和NDM菌株的比较研究
Antibiotics (Basel). 2023 May 8;12(5):872. doi: 10.3390/antibiotics12050872.
3
Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients-A Narrative Review.重症患者β-内酰胺类抗生素治疗药物监测的最新进展——一项叙述性综述
Antibiotics (Basel). 2023 Mar 13;12(3):568. doi: 10.3390/antibiotics12030568.
4
The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review.兽医学中抗生素的使用与抗菌药物耐药性：一种复杂现象的叙述性综述
Antibiotics (Basel). 2023 Mar 1;12(3):487. doi: 10.3390/antibiotics12030487.
5
Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the 'Maximum Tolerable Dose'.为何我们可能需要更高剂量的β-内酰胺类抗生素：引入“最大耐受剂量”
Antibiotics (Basel). 2022 Jul 4;11(7):889. doi: 10.3390/antibiotics11070889.
6
Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study.急性-on-慢性肝衰竭改变了接受持续血液透析的重症患者美罗培南的药代动力学：一项观察性研究。
Ann Intensive Care. 2020 Apr 22;10(1):48. doi: 10.1186/s13613-020-00666-8.
7
Peramivir for Influenza A and B Viral Infections: A Pharmacokinetic Case Series.帕拉米韦治疗甲型和乙型流感病毒感染：药代动力学病例系列。
Pharmacotherapy. 2019 Nov;39(11):1060-1065. doi: 10.1002/phar.2330. Epub 2019 Oct 4.
8
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review.需要多少次抗生素暴露才能抑制革兰氏阴性菌的耐药性出现？一项系统性综述。
Clin Pharmacokinet. 2019 Nov;58(11):1407-1443. doi: 10.1007/s40262-019-00791-z.
9
Optimization of Antimicrobial Treatment to Minimize Resistance Selection.优化抗菌治疗以最大程度减少耐药性选择。
Microbiol Spectr. 2018 May;6(3). doi: 10.1128/microbiolspec.ARBA-0018-2017.
10
Individualising Therapy to Minimize Bacterial Multidrug Resistance.个体化治疗以最小化细菌的多重耐药性。
Drugs. 2018 Apr;78(6):621-641. doi: 10.1007/s40265-018-0891-9.

本文引用的文献

1
Low correlation between MIC and mutant prevention concentration.最低抑菌浓度（MIC）与突变预防浓度之间的相关性较低。
Antimicrob Agents Chemother. 2006 Jan;50(1):403-4. doi: 10.1128/AAC.50.1.403-404.2006.
2
Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?美国肺炎链球菌的抗菌药物耐药性：我们是否已开始在某些抗菌药物类别的耐药性问题上有所转机？
Clin Infect Dis. 2005 Jul 15;41(2):139-48. doi: 10.1086/430906. Epub 2005 Jun 7.
3
Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli.环丙沙星对大肠埃希菌尿路感染分离株的突变预防浓度。
J Antimicrob Chemother. 2005 Jun;55(6):938-43. doi: 10.1093/jac/dki136. Epub 2005 Apr 28.
4
Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.对莫西沙星和左氧氟沙星敏感性降低的肺炎链球菌突变体的筛选。
Antimicrob Agents Chemother. 2002 Feb;46(2):522-4. doi: 10.1128/AAC.46.2.522-524.2002.
5
Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.限制抗生素抗性突变体的选择：源自氟喹诺酮类研究的通用策略。
Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S147-56. doi: 10.1086/321841.
6
Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.拉丁美洲引起尿路感染的环丙沙星敏感大肠埃希菌分离株中gyrA单点突变的发生情况。
Diagn Microbiol Infect Dis. 2000 Jan;36(1):61-4. doi: 10.1016/s0732-8893(99)00121-2.
7
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.氟喹诺酮类药物的DNA拓扑异构酶靶点：一种避免细菌耐药性的策略。
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13991-6. doi: 10.1073/pnas.94.25.13991.